Víctor Fernández-Dueñas - Publications

Affiliations: 
2007-2023 Department of Pathology and Experimental Therapeutics Universitat de Barcelona, Barcelona, Cataluña, Spain 

66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Taura J, López-Cano M, Fernández-Dueñas V, Ciruela F. Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols. 3: e794. PMID 37289022 DOI: 10.1002/cpz1.794  0.815
2023 Morató X, Fernández-Dueñas V, Pérez-Villamor P, Valle-León M, Vela JM, Merlos M, Burgueño J, Ciruela F. Development of a Novel σ Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells. Acs Chemical Neuroscience. PMID 37191585 DOI: 10.1021/acschemneuro.3c00206  0.81
2022 Prieto-Díaz R, González-Gómez M, Fojo-Carballo H, Azuaje J, El Maatougui A, Majellaro M, Loza MI, Brea J, Fernández-Dueñas V, Paleo MR, Díaz-Holguín A, Garcia-Pinel B, Mallo-Abreu A, Estévez JC, Andújar-Arias A, et al. Exploring the Effect of Halogenation in a Series of Potent and Selective A Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. PMID 36517209 DOI: 10.1021/acs.jmedchem.2c01768  0.574
2022 Crans RAJ, Wouters E, Valle-León M, Taura J, Massari CM, Fernández-Dueñas V, Stove CP, Ciruela F. Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders. Frontiers in Pharmacology. 13: 1075433. PMID 36467044 DOI: 10.3389/fphar.2022.1075433  0.807
2022 Sarasola LI, Del Torrent CL, Pérez-Arévalo A, Argerich J, Casajuana-Martín N, Chevigné A, Fernández-Dueñas V, Ferré S, Pardo L, Ciruela F. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A-A receptor heteromer formation and function. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113896. PMID 36279718 DOI: 10.1016/j.biopha.2022.113896  0.578
2021 Fernández-Dueñas V, Bonaventura J, Aso E, Luján R, Ferré S, Ciruela F. Overcoming the challenges of detecting gpcr oligomerization in the brain. Current Neuropharmacology. PMID 34736381 DOI: 10.2174/1570159X19666211104145727  0.618
2021 Hüll K, Fernández-Dueñas V, Schönberger M, López-Cano M, Trauner D, Ciruela F. Optical Control of Adenosine-Mediated Pain Modulation. Bioconjugate Chemistry. PMID 34448572 DOI: 10.1021/acs.bioconjchem.1c00387  0.79
2021 López-Cano M, Font J, Aso E, Sahlholm K, Cabré G, Giraldo J, De Koninck Y, Hernando J, Llebaria A, Fernández-Dueñas V, Ciruela F. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. British Journal of Pharmacology. PMID 34363210 DOI: 10.1111/bph.15645  0.765
2021 Morató X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borràs E, Sabidó E, Petäjä-Repo UE, Fernández-Dueñas V, Ferrer I, Svenningsson P, Ciruela F. Ecto-GPR37: a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 10: 8. PMID 33637132 DOI: 10.1186/s40035-021-00232-7  0.788
2020 Valle-León M, Callado LF, Aso E, Cajiao-Manrique MM, Sahlholm K, López-Cano M, Soler C, Altafaj X, Watanabe M, Ferré S, Fernández-Dueñas V, Menchón JM, Ciruela F. Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33010795 DOI: 10.1038/s41386-020-00872-9  0.796
2020 Crans RAJ, Wouters E, Valle-León M, Taura J, Massari CM, Fernández-Dueñas V, Stove CP, Ciruela F. Striatal Dopamine D-Muscarinic Acetylcholine M Receptor-Receptor Interaction in a Model of Movement Disorders. Frontiers in Pharmacology. 11: 194. PMID 32231561 DOI: 10.3389/Fphar.2020.00194  0.814
2020 Fernández-Dueñas V, Qian M, Argerich J, Amaral C, Risseeuw MDP, Van Calenbergh S, Ciruela F. Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators. Molecules (Basel, Switzerland). 25. PMID 32230915 DOI: 10.3390/Molecules25071532  0.566
2020 Köfalvi A, Moreno E, Cordomí A, Cai NS, Fernández-Dueñas V, Ferreira SG, Guixà-González R, Sánchez-Soto M, Yano H, Casadó-Anguera V, Cunha RA, Sebastião AM, Ciruela F, Pardo L, Casadó V, et al. Control of glutamate release by complexes of adenosine and cannabinoid receptors. Bmc Biology. 18: 9. PMID 31973708 DOI: 10.1186/S12915-020-0739-0  0.6
2019 Lanznaster D, Massari CM, Marková V, Šimková T, Duroux R, Jacobson KA, Fernández-Dueñas V, Tasca CI, Ciruela F. Adenosine A-A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects. Cells. 8. PMID 31847113 DOI: 10.3390/Cells8121630  0.556
2019 López-Cano M, Fernández-Dueñas V, Ciruela F. Proximity Ligation Assay Image Analysis Protocol: Addressing Receptor-Receptor Interactions. Methods in Molecular Biology (Clifton, N.J.). 2040: 41-50. PMID 31432474 DOI: 10.1007/978-1-4939-9686-5_3  0.766
2019 Fernández-Dueñas V, Gómez-Soler M, Valle-León M, Watanabe M, Ferrer I, Ciruela F. Revealing Adenosine A-Dopamine D Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. International Journal of Molecular Sciences. 20. PMID 31340557 DOI: 10.3390/Ijms20143600  0.816
2019 Soto D, Olivella M, Grau C, Armstrong J, Alcon C, Gasull X, Santos-Gómez A, Locubiche S, de Salazar MG, García-Díaz R, Gratacòs-Batlle E, Ramos-Vicente D, Chu-Van E, Colsch B, Fernández-Dueñas V, et al. l-Serine dietary supplementation is associated with clinical improvement of loss-of-function -related pediatric encephalopathy. Science Signaling. 12. PMID 31213567 DOI: 10.1126/Scisignal.Aaw0936  0.493
2019 López-Cano M, Font J, Llebaria A, Fernández-Dueñas V, Ciruela F. Optical Modulation of Metabotropic Glutamate Receptor Type 5 In Vivo Using a Photoactive Drug. Methods in Molecular Biology (Clifton, N.J.). 1947: 351-359. PMID 30969427 DOI: 10.1007/978-1-4939-9121-1_20  0.794
2019 Zanatta AP, Gonçalves R, Zanatta L, de Oliveria GT, Moraes ALL, Zamoner A, Fernández-Dueñas V, Lanznaster D, Ciruela F, Tasca CI, Delalande C, Menegaz D, Silva FRMB. New ionic targets of 3,3',5'-triiodothyronine at the plasma membrane of rat Sertoli cells. Biochimica Et Biophysica Acta. Biomembranes. PMID 30639285 DOI: 10.1016/J.Bbamem.2019.01.002  0.423
2019 Aso E, Fernández-Dueñas V, López-Cano M, Taura J, Watanabe M, Ferrer I, Luján R, Ciruela F. Adenosine A-Cannabinoid CB Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ-Tetrahydrocannabinol-Induced Cognitive Impairment. Molecular Neurobiology. PMID 30610611 DOI: 10.1007/S12035-018-1456-3  0.816
2018 Morató X, Gonçalves FQ, Lopes JP, Jauregui O, Soler C, Fernández-Dueñas V, Cunha RA, Ciruela F. Chronic adenosine A receptor blockade induces locomotor sensitization and potentiates striatal LTD in GPR37 deficient mice. Journal of Neurochemistry. PMID 30578680 DOI: 10.1111/Jnc.14653  0.795
2018 Sahlholm K, Valle-León M, Fernández-Dueñas V, Ciruela F. Dopamine receptor heteromers: biasing antipsychotics. Future Medicinal Chemistry. PMID 30518245 DOI: 10.4155/Fmc-2018-0335  0.826
2018 Tasca CI, Lanznaster D, Oliveira KA, Fernández-Dueñas V, Ciruela F. Neuromodulatory Effects of Guanine-Based Purines in Health and Disease. Frontiers in Cellular Neuroscience. 12: 376. PMID 30459558 DOI: 10.3389/Fncel.2018.00376  0.546
2018 Núñez F, Taura J, Camacho J, López-Cano M, Fernández-Dueñas V, Castro N, Castro J, Ciruela F. PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers in Pharmacology. 9: 1200. PMID 30405415 DOI: 10.3389/Fphar.2018.01200  0.823
2018 Gómez-Soler M, Cordobilla B, Morató X, Fernández-Dueñas V, Domingo JC, Ciruela F. Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism. Frontiers in Neuroscience. 12: 604. PMID 30233293 DOI: 10.3389/Fnins.2018.00604  0.792
2018 Jung C, Fernández-Dueñas V, Plata C, Garcia-Elias A, Ciruela F, Fernández-Fernández JM, Valverde MA. Functional coupling of GABA receptors and the channel TRPV4 mediates rapid progesterone signaling in the oviduct. Science Signaling. 11. PMID 30108184 DOI: 10.1126/Scisignal.Aam6558  0.514
2018 Morató X, Luján R, Gonçalves N, Watanabe M, Altafaj X, Carvalho AL, Fernández-Dueñas V, Cunha RA, Ciruela F. Metabotropic glutamate type 5 receptor requires contactin-associated protein 1 to control memory formation. Human Molecular Genetics. PMID 30010864 DOI: 10.1093/Hmg/Ddy264  0.784
2018 Sahlholm K, Valle-Leon M, Taura J, Fernandez-Duenas V, Ciruela F. Effects of the Dopamine Stabilizer, Pridopidine, on Basal and Phencyclidine-Induced Locomotion: Role of Dopamine D2 and Sigma-1 Receptors. Cns & Neurological Disorders Drug Targets. PMID 29952269 DOI: 10.2174/1871527317666180627103337  0.82
2018 Taura J, Nolen EG, Cabré G, Hernando J, Squarcialupi L, López-Cano M, Jacobson KA, Fernández-Dueñas V, Ciruela F. Remote control of movement disorders using a photoactive adenosine A receptor antagonist. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29859955 DOI: 10.1016/J.Jconrel.2018.05.033  0.843
2018 Sahlholm K, Valle-León M, Fernández-Dueñas V, Ciruela F. Pridopidine Reverses Phencyclidine-Induced Memory Impairment. Frontiers in Pharmacology. 9: 338. PMID 29692729 DOI: 10.3389/Fphar.2018.00338  0.81
2018 Fernandez-Duenas V, Ferré S, Ciruela F. Adenosine A-dopamine Dreceptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics. Neural Regeneration Research. 13: 241-243. PMID 29557372 DOI: 10.4103/1673-5374.226388  0.519
2018 Font J, López-Cano M, Notartomaso S, Scarselli P, Di Prieto P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 7. PMID 29313801 DOI: 10.7554/Elife.34752  0.784
2017 López-Cano M, Fernández-Dueñas V, Llebaria A, Ciruela F. Formalin Murine Model of Pain. Bio-Protocol. 7: e2628. PMID 34595296 DOI: 10.21769/BioProtoc.2628  0.743
2017 Fernández-Dueñas V, Pérez-Arévalo A, Altafaj X, Ferré S, Ciruela F. Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease. Frontiers in Neuroscience. 11: 652. PMID 29213228 DOI: 10.3389/Fnins.2017.00652  0.571
2017 Massari CM, López-Cano M, Núñez F, Fernández-Dueñas V, Tasca CI, Ciruela F. Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. Frontiers in Pharmacology. 8: 700. PMID 29046640 DOI: 10.3389/Fphar.2017.00700  0.784
2017 Morató X, Luján R, López-Cano M, Gandía J, Stagljar I, Watanabe M, Cunha RA, Fernández-Dueñas V, Ciruela F. The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo. Scientific Reports. 7: 9452. PMID 28842709 DOI: 10.1038/S41598-017-10147-X  0.844
2017 Sahlholm K, Gómez-Soler M, Valle-León M, López-Cano M, Taura JJ, Ciruela F, Fernández-Dueñas V. Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression. Molecular Neurobiology. PMID 28779351 DOI: 10.1007/S12035-017-0696-Y  0.782
2017 Soto D, Olivella M, Grau C, Armstrong J, Alcon C, Gasull X, Gómez de Salazar M, Gratacòs-Batlle E, Ramos-Vicente D, Fernández-Dueñas V, Ciruela F, Bayés À, Sindreu C, López-Sala A, García-Cazorla À, et al. Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement. Biological Psychiatry. PMID 28734458 DOI: 10.1016/J.Biopsych.2017.05.028  0.468
2017 Oliveira PA, Dalton JAR, López-Cano M, Ricarte A, Morató X, Matheus FC, Cunha AS, Müller CE, Takahashi RN, Fernández-Dueñas V, Giraldo J, Prediger RD, Ciruela F. Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia. Scientific Reports. 7: 1857. PMID 28500295 DOI: 10.1038/S41598-017-02037-Z  0.847
2017 Font J, López-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 6. PMID 28395733 DOI: 10.7554/Elife.23545  0.807
2017 Fernández-Dueñas V, Azuaje J, Morató X, Cordobilla B, Domingo JC, Sotelo E, Ciruela F. Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid. Molecules (Basel, Switzerland). 22. PMID 28264466 DOI: 10.3390/Molecules22030366  0.807
2017 Fernández-Dueñas V, Burgueño J, Ciruela F. Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor. Frontiers in Pharmacology. 8: 4. PMID 28144220 DOI: 10.3389/Fphar.2017.00004  0.824
2016 Rial D, Morató X, Real JI, Gonçalves FQ, Stagljar I, Pereira FC, Fernández-Dueñas V, Cunha RA, Ciruela F. Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses. Neuroscience Letters. PMID 28007645 DOI: 10.1016/J.Neulet.2016.12.040  0.766
2016 Gaitán-Peñas H, Gradogna A, Laparra-Cuervo L, Solsona C, Fernández-Dueñas V, Barrallo-Gimeno A, Ciruela F, Lakadamyali M, Pusch M, Estévez R. Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes. Biophysical Journal. 111: 1429-1443. PMID 27705766 DOI: 10.1016/J.Bpj.2016.08.030  0.458
2016 Di Liberto V, Mudò G, Garozzo R, Frinchi M, Fernandez-Dueñas V, Di Iorio P, Ciccarelli R, Caciagli F, Condorelli DF, Ciruela F, Belluardo N. The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation. Frontiers in Pharmacology. 7: 158. PMID 27378923 DOI: 10.3389/Fphar.2016.00158  0.609
2015 Taura J, Fernández-Dueñas V, Ciruela F. Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. 67: 17.17.1-17.17.16. PMID 26061241 DOI: 10.1002/0471143030.Cb1717S67  0.836
2015 Ciruela F, Fernández-Dueñas V, Jacobson KA. Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. Neuropharmacology. PMID 25890205 DOI: 10.1016/J.Neuropharm.2015.04.001  0.57
2015 Gandía J, Morató X, Stagljar I, Fernández-Dueñas V, Ciruela F. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent. Behavioural Brain Research. 288: 103-6. PMID 25862943 DOI: 10.1016/J.Bbr.2015.04.001  0.843
2015 Lopes JP, Morató X, Souza C, Pinhal C, Machado NJ, Canas PM, Silva HB, Stagljar I, Gandía J, Fernández-Dueñas V, Luján R, Cunha RA, Ciruela F. The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system. Journal of Neurochemistry. 134: 135-46. PMID 25824528 DOI: 10.1111/Jnc.13109  0.809
2015 Ciruela F, Fernández-Dueñas V. GPCR oligomerization analysis by means of BRET and dFRAP. Methods in Molecular Biology (Clifton, N.J.). 1272: 133-41. PMID 25563182 DOI: 10.1007/978-1-4939-2336-6_10  0.494
2015 Fernández-Dueñas V, Taura JJ, Cottet M, Gómez-Soler M, López-Cano M, Ledent C, Watanabe M, Trinquet E, Pin JP, Luján R, Durroux T, Ciruela F. Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats. Disease Models & Mechanisms. 8: 57-63. PMID 25398851 DOI: 10.1242/Dmm.018143  0.795
2014 Fernández-Dueñas V, Gómez-Soler M, López-Cano M, Taura JJ, Ledent C, Watanabe M, Jacobson KA, Vilardaga JP, Ciruela F. Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism. Acs Chemical Biology. 9: 2496-501. PMID 25268872 DOI: 10.1021/Cb5005383  0.82
2014 Bahamonde MI, Taura J, Paoletta S, Gakh AA, Chakraborty S, Hernando J, Fernández-Dueñas V, Jacobson KA, Gorostiza P, Ciruela F. Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand. Bioconjugate Chemistry. 25: 1847-54. PMID 25248077 DOI: 10.1021/Bc5003373  0.845
2014 Ciruela F, Vallano A, Cuffí ML, Carbonell L, Sánchez S, Arnau JM, Tasca C, Fernández-Dueñas V, Gómez-Soler M. Deciphering G protein-coupled receptor biology with fluorescence-based methods. Current Pharmaceutical Biotechnology. 15: 962-70. PMID 25213309 DOI: 10.2174/1389201015666140909125119  0.823
2014 Ciruela F, Jacobson KA, Fernández-Dueñas V. Portraying G protein-coupled receptors with fluorescent ligands. Acs Chemical Biology. 9: 1918-28. PMID 25010291 DOI: 10.1021/Cb5004042  0.55
2014 Villar-Menéndez I, Nuñez F, Díaz-Sánchez S, Albasanz JL, Taura J, Fernández-Dueñas V, Ferrer I, Martín M, Ciruela F, Barrachina M. Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation. Purinergic Signalling. 10: 523-8. PMID 24943396 DOI: 10.1007/S11302-014-9417-4  0.807
2013 Gandía J, Fernández-Dueñas V, Morató X, Caltabiano G, González-Muñiz R, Pardo L, Stagljar I, Ciruela F. The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain. Journal of Neurochemistry. 125: 362-72. PMID 23398388 DOI: 10.1111/Jnc.12196  0.826
2012 Fernández-Dueñas V, Poveda R, Sánchez S, Ciruela F. Synergistic interaction between fentanyl and a tramadol: paracetamol combination on the inhibition of nociception in mice. Journal of Pharmacological Sciences. 118: 299-302. PMID 22302020 DOI: 10.1254/Jphs.11161Sc  0.505
2011 Vallano A, Fernandez-Duenas V, Pedros C, Arnau JM, Ciruela F. An update on adenosine A2A receptors as drug target in Parkinson's disease. Cns & Neurological Disorders Drug Targets. 10: 659-69. PMID 21838670 DOI: 10.2174/187152711797247803  0.687
2011 López-Hernández T, Sirisi S, Capdevila-Nortes X, Montolio M, Fernández-Dueñas V, Scheper GC, van der Knaap MS, Casquero P, Ciruela F, Ferrer I, Nunes V, Estévez R. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Human Molecular Genetics. 20: 3266-77. PMID 21624973 DOI: 10.1093/Hmg/Ddr238  0.409
2011 Caballero M, Núñez F, Ahern S, Cuffí ML, Carbonell L, Sánchez S, Fernández-Dueñas V, Ciruela F. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD). Neuroscience Letters. 494: 44-8. PMID 21362462 DOI: 10.1016/J.Neulet.2011.02.050  0.443
2011 Fernández-Dueñas V, Poveda R, Fernández A, Sánchez S, Planas E, Ciruela F. Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain. Pharmacology, Biochemistry, and Behavior. 98: 331-6. PMID 21296105 DOI: 10.1016/J.Pbb.2011.01.023  0.512
2010 Ciruela F, Vilardaga JP, Fernández-Dueñas V. Lighting up multiprotein complexes: lessons from GPCR oligomerization. Trends in Biotechnology. 28: 407-15. PMID 20542584 DOI: 10.1016/J.Tibtech.2010.05.002  0.508
2010 Fernández-Dueñas V, Ciruela F, Gandía J, Sánchez S, Planas E, Poveda R. Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice. European Journal of Pharmacology. 638: 72-7. PMID 20435034 DOI: 10.1016/J.Ejphar.2010.04.022  0.795
2010 Ciruela F, Albergaria C, Soriano A, Cuffí L, Carbonell L, Sánchez S, Gandía J, Fernández-Dueñas V. Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling. Biochimica Et Biophysica Acta. 1798: 9-20. PMID 19883624 DOI: 10.1016/J.Bbamem.2009.10.016  0.838
2009 Canela L, Fernández-Dueñas V, Albergaria C, Watanabe M, Lluís C, Mallol J, Canela EI, Franco R, Luján R, Ciruela F. The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function. Journal of Neurochemistry. 111: 555-67. PMID 19694902 DOI: 10.1111/J.1471-4159.2009.06348.X  0.828
Show low-probability matches.